Figure 2.
Evolution of VAS symptoms in patients with refractory chronic rhinosinusitis and nasal polyps, before and after 24-week treatment with 100 mg of mepolizumab every 4 weeks.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.